Puneet Souda
Stock Analyst at Leerink Partners
(1.97)
# 3,002
Out of 5,182 analysts
196
Total ratings
47.85%
Success rate
-1.01%
Average return
Main Sectors:
Stocks Rated by Puneet Souda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GH Guardant Health | Maintains: Outperform | $170 → $180 | $83.09 | +116.63% | 8 | Feb 20, 2026 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $545 → $580 | $470.22 | +23.35% | 20 | Oct 22, 2025 | |
| CYRX Cryoport | Upgrades: Outperform | $16 | $10.10 | +58.42% | 7 | Aug 6, 2025 | |
| MASS 908 Devices | Upgrades: Outperform | $12 | $6.74 | +78.04% | 7 | Aug 5, 2025 | |
| QTRX Quanterix | Downgrades: Market Perform | $12 → $8 | $3.34 | +139.52% | 12 | Apr 30, 2025 | |
| NEO NeoGenomics | Downgrades: Market Perform | $25 → $9 | $9.02 | -0.22% | 10 | Apr 30, 2025 | |
| MYGN Myriad Genetics | Downgrades: Market Perform | $30 → $21 | $4.84 | +333.88% | 7 | Dec 9, 2024 | |
| VCYT Veracyte | Maintains: Outperform | $35 → $40 | $33.43 | +19.65% | 14 | Oct 17, 2024 | |
| NTRA Natera | Maintains: Outperform | $140 → $150 | $200.17 | -25.06% | 7 | Oct 17, 2024 | |
| WAT Waters | Upgrades: Outperform | $325 → $375 | $300.73 | +24.70% | 15 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $50 → $35 | $24.69 | +41.76% | 11 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $170 → $145 | $114.87 | +26.23% | 19 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $300 | $178.98 | +67.62% | 1 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $249 → $250 | $126.92 | +96.97% | 19 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $110 | $53.51 | +105.57% | 6 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $200 | $117.43 | +70.31% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $20 → $18 | $4.16 | +332.69% | 6 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $6 | $1.40 | +328.57% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $45 → $30 | $59.15 | -49.28% | 6 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $85 → $87 | $36.26 | +139.93% | 13 | May 5, 2022 |
Guardant Health
Feb 20, 2026
Maintains: Outperform
Price Target: $170 → $180
Current: $83.09
Upside: +116.63%
Thermo Fisher Scientific
Oct 22, 2025
Maintains: Outperform
Price Target: $545 → $580
Current: $470.22
Upside: +23.35%
Cryoport
Aug 6, 2025
Upgrades: Outperform
Price Target: $16
Current: $10.10
Upside: +58.42%
908 Devices
Aug 5, 2025
Upgrades: Outperform
Price Target: $12
Current: $6.74
Upside: +78.04%
Quanterix
Apr 30, 2025
Downgrades: Market Perform
Price Target: $12 → $8
Current: $3.34
Upside: +139.52%
NeoGenomics
Apr 30, 2025
Downgrades: Market Perform
Price Target: $25 → $9
Current: $9.02
Upside: -0.22%
Myriad Genetics
Dec 9, 2024
Downgrades: Market Perform
Price Target: $30 → $21
Current: $4.84
Upside: +333.88%
Veracyte
Oct 17, 2024
Maintains: Outperform
Price Target: $35 → $40
Current: $33.43
Upside: +19.65%
Natera
Oct 17, 2024
Maintains: Outperform
Price Target: $140 → $150
Current: $200.17
Upside: -25.06%
Waters
Aug 1, 2024
Upgrades: Outperform
Price Target: $325 → $375
Current: $300.73
Upside: +24.70%
Jun 5, 2023
Maintains: Outperform
Price Target: $50 → $35
Current: $24.69
Upside: +41.76%
May 24, 2023
Maintains: Outperform
Price Target: $170 → $145
Current: $114.87
Upside: +26.23%
May 1, 2023
Initiates: Outperform
Price Target: $300
Current: $178.98
Upside: +67.62%
Feb 8, 2023
Maintains: Outperform
Price Target: $249 → $250
Current: $126.92
Upside: +96.97%
Feb 3, 2023
Maintains: Outperform
Price Target: $125 → $110
Current: $53.51
Upside: +105.57%
Jan 6, 2023
Maintains: Outperform
Price Target: $230 → $200
Current: $117.43
Upside: +70.31%
Jan 6, 2023
Maintains: Outperform
Price Target: $20 → $18
Current: $4.16
Upside: +332.69%
Nov 29, 2022
Initiates: Outperform
Price Target: $6
Current: $1.40
Upside: +328.57%
Nov 21, 2022
Maintains: Market Perform
Price Target: $45 → $30
Current: $59.15
Upside: -49.28%
May 5, 2022
Maintains: Outperform
Price Target: $85 → $87
Current: $36.26
Upside: +139.93%